Literature DB >> 503125

Tamoxifen in malignant melanoma.

R A Nesbit, R L Woods, M H Tattersall, R M Fox, J F Forbes, I R MacKay, M Goodyear.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 503125     DOI： 10.1056/nejm197911293012218

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Biochim Biophys Acta       Date:  2015-05-09

2.  Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.

Authors:  Yoshihiro Suzuki; Norio Aoyama; Junji Minamide; Ken Takata; Takashi Ogata
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

3.  Steroid hormone receptors in human melanoma.

Authors:  H J Grill; P Benes; B Manz; P Schramm; B Morsches; G W Korting; K Pollow
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

4.  Topical toremifene: a new approach for cutaneous melanoma?

Authors:  J Maenpaa; T Dooley; G Wurz; J VandeBerg; E Robinson; V Emshoff; P Sipila; V Wiebe; C Day; M DeGregorio
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Alopecia with endocrine therapies in patients with cancer.

Authors:  Vishal Saggar; Shenhong Wu; Maura N Dickler; Mario E Lacouture
Journal:  Oncologist       Date:  2013-09-13

6.  Oral contraceptive use and risk of melanoma in premenopausal women.

Authors:  D Feskanich; D J Hunter; W C Willett; D Spiegelman; M J Stampfer; F E Speizer; G A Colditz
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.